Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031200220Completed
Open-label, single-arm trial of Polypodium leucotomos. Primary endpoints: Serum midazolam AUC and Serum midazolam Cmax. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031200220.